
In the Literature ...
Ylhäinen A, Rantala M, Thomson K, et al. Placebo is non-inferior to postoperative antimicrobial treatment in uncomplicated canine pyometra – a double-blinded randomized controlled trial. Vet J. 2025;314:106449. doi:10.1016/j.tvjl.2025.106449
The Research …
Pyometra is a common surgical condition that has been associated with concurrent bacteriuria in ≈33% of dogs.1 This bacteriuria, in addition to the potential for surgical site infections (SSIs), has been used to advocate for routine postoperative antimicrobial use.
In this double-blinded, randomized, placebo-controlled clinical trial, dogs with uncomplicated pyometra (n = 152) received a single perioperative administration of sulfadoxine-trimethoprim (SXT, 30 mg/kg IV) followed by oral placebo or SXT (19 mg/kg PO) every 12 hours for 5 days postoperatively. Both the postoperative incidence of SSIs within 30 days and clinical UTIs within 12 days were assessed.
Despite the presence of perioperative bacteriuria in 48 dogs (placebo group, 22; SXT group, 26), no dogs in the placebo group (0%) and 2 dogs in the SXT group (3.9%) developed clinical UTIs within 12 days of follow up. Similarly, SSIs developed in 2.7% of dogs in the placebo group and in 7.8% of dogs in the SXT group, which is consistent with SSI rates previously reported for clean-contaminated surgeries.2 Overall, a 5-day postoperative SXT course did not reduce the incidence of clinical UTIs or SSIs in dogs undergoing surgery for uncomplicated pyometra, and most dogs with bacteriuria did not develop clinical UTIs. These findings support omission of postoperative antimicrobials in dogs with uncomplicated pyometras that receive perioperative antimicrobials, potentially reducing antimicrobial resistance, pet owner cost, and medication adverse effects.
… The Takeaways
Key pearls to put into practice:
The most common infectious complications following pyometra surgery include SSIs and UTIs1; however, most dogs with documented perioperative or postoperative bacteriuria do not develop clinical signs of UTIs. Thus, documentation of bacteriuria in the absence of clinical signs (eg, dysuria, pollakiuria, hematuria) should not indicate continued antibiotic administration postoperatively.
Escherichia coli, a gram-negative rod, is the most common pathogen diagnosed in canine pyometra.1 The source of E coli that results in pyometra is unknown but likely ascends from the GI tract.3 First-line antibiotics (eg, SXT) are preferred over broad-spectrum antibiotics (eg, fluoroquinolones) in uncomplicated conditions and should be limited to the perioperative period to reduce antimicrobial resistance.
Sulfonamides (eg, sulfadiazine, sulfamethoxazole) alone are bacteriostatic; however, potentiation with trimethoprim makes sulfonamides bactericidal. Potentiated sulfonamides inhibit the bacterial folic acid synthesis pathway and ultimately inhibit thymidine and, subsequently, DNA synthesis. These drugs are effective against most gram-positive and gram-negative aerobic bacteria,4 although Doberman pinschers, Samoyeds, and miniature schnauzers appear predisposed to sulfonamide-induced immune-mediated disease.5,6
You are reading 2-Minute Takeaways, a research summary resource presented by Clinician’s Brief. Clinician’s Brief does not conduct primary research.